IDiyas

For the Inventor, By the Inventor

Handa, Japan

Kunio Satake

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 97(Granted Patents)


Location History:

  • Aichi-ken, JP (2000 - 2001)
  • Chita-gun, JP (2002)
  • Handa, JP (1992 - 2003)

Company Filing History:

goldMedal16 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1992-2003

Loading Chart...
16 patents (USPTO):Explore Patents
1. 6649767 - Process for preparing 1,4-dihydropyridine compounds (2003-11-18),
2. 6506775 - Substituted benzylaminopiperidine compounds (2003-01-14),
3. 6416979 - 5-substituted picolinic acid compounds production by Marasmiellus sp (2002-07-09),
4. 6329396 - Substituted benzylaminopiperidine compounds (2001-12-11),
5. 6194442 - 5-substituted picolinic acid compounds and their method of use (2001-02-27),
6. 6034107 - 5-Substituted picolinic acid compounds and their production process (2000-03-07),
7. 5869499 - Benzyloxyquinuclidines as substance P antagonists (1999-02-09),
8. 5852038 - Substituted 3-aminoquinuclidines (1998-12-22),
9. 5837711 - Substituted quinuclidines as substance P antagonists (1998-11-17),
10. 5741797 - Heteroatom substituted alkyl benzylaminoquinuclidines (1998-04-21),
11. 5721255 - Substituted benzylamino nitrogen containing non-aromatic heterocycles (1998-02-24),
12. 5716965 - Substituted 3-aminoquinuclidines (1998-02-10),
13. 5604241 - Substituted benzylaminoquinuclidines as substance P antagonists (1997-02-18),
14. 5569662 - Quinuclidine derivatives as substance P antagonists (1996-10-29),
15. 5504095 - Aminobenzosultam derivatives as lipoxygenase inhibitors (1996-04-02),

Title: Kunio Satake: Innovator in Pharmaceutical Chemistry

Introduction

Kunio Satake, based in Handa, Japan, is a distinguished inventor with a remarkable portfolio of 16 patents. His contributions to the field of pharmaceutical chemistry have made significant strides in developing new compounds that hold promise for therapeutic applications. Currently, he is affiliated with Pfizer Corporation, a leading global biopharmaceutical company.

Latest Patents

Among his latest patents, Kunio Satake has developed innovative methods for producing various chemical compounds, including a "Process for preparing 1,4-dihydropyridine compounds" and "Substituted benzylaminopiperidine compounds." These inventions showcase his expertise and focus on creating valuable pharmaceuticals that address various medical needs.

Career Highlights

Throughout his career, Kunio has demonstrated a consistent commitment to advancing drug development through his research and patenting efforts. His affiliation with Pfizer Corporation has provided him with an excellent platform to contribute to cutting-edge pharmaceutical innovations and collaborate with some of the industry's brightest minds.

Collaborations

Kunio has had the privilege of working alongside talented colleagues, including Hiroaki Wakabayashi and Masami Nakane. Their collaborative efforts signify the importance of teamwork in scientific research and innovation, enhancing the impact of their collective work on the pharmaceutical landscape.

Conclusion

In summary, Kunio Satake stands out as a prominent figure in the realm of pharmaceutical chemistry. His extensive patent portfolio and continued dedication to innovation reflect his significant contributions to the industry. As he continues his work at Pfizer Corporation, the influence of his inventions is likely to expand, ultimately improving therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…